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Experiments to analyze the functions of the equine herpesvirus 1 (EHV-1) glycoprotein gB were performed. Cell lines
which stably expressed either the full-length EHV-1 gB or only the extracellular portion of gB (amino acids 1 to 844) were
constructed and were termed TCgBf and TCgBD, respectively. Using the cell line TCgBf, a gB-negative viral mutant, L11DgB,
was generated by replacing a 2.1-kb BglII–NruI fragment in the EHV-1 strain RacL11 gB with the Escherichia coli LacZ
gene. EHV-1 strain RacL11, the modified live vaccine strain RacH, and L11DgB were used for functional studies. It was
shown that: (i) EHV-1 gB is essential for virus growth in vitro since gB-negative L11DgB exhibited titers of 10 PFU/ml
when grown and titrated on noncomplementing cells. (ii) The cell line expressing truncated gB (TCgBD) did not complement
for the growth of L11DgB, but the RacH virus grew to titers comparable to those of RacL11 in all cell lines tested. Since
RacH had amino acids 944– 980 of gB replaced by 7 missense amino acids as determined by nucleotide sequence analysis,
the extreme carboxyterminus but not a domain between amino acid residues 845 and 943, probably the transmembrane
domain, of EHV-1 gB is dispensable for virus growth in cultured cells. (iii) Single infected cells but no plaque formation
were observed after infection of noncomplementing cells with L11DgB, demonstrating the requirement of EHV-1 gB for
direct cell-to-cell spread of infection. (iv) The attachment of gB-negative L11DgB virions to target cells was similar to both
phenotypically complemented L11DgB and parent RacL11 virus. (v) L11DgB viral titers could be enhanced by using the
fusogen polyethylene glycol (PEG). The increase of L11DgB titers by PEG treatment, however, was considerably lower
compared to gB-negative pseudorabies virus, suggesting that EHV-1 gB might not be as stringently required for virus
penetration as are its homologs in other Alphaherpesvirinae. q 1997 Academic Press
INTRODUCTION mologous protein (Whalley et al., 1989). Analyses of gp14
(referred to as EHV-1 gB in this communication) haveEquine herpesvirus 1 (EHV-1), a member of the Alpha-
shown that the glycoprotein is regulated as a b–g classherpesvirinae, is the causative agent of respiratory dis-
molecule and that an Mr 118,000 primary translationease, abortions, and neurological disorders in horses
product is N-glycosylated to yield an Mr 138,000 protein(Allen and Bryans, 1986; O’Callaghan et al., 1983). The
(Sullivan et al., 1989). This glycosylated precursor mole-entire genome of EHV-1 has been sequenced (Telford et
cule is cleaved and the two subunits form disulfide-al., 1992) and genes encoding for glycoproteins which
bonded dimers both in infected cells and in mature viri-are homologous to the herpes simplex virus type 1 (HSV-
ons (Meredith et al., 1989; Sullivan et al., 1989).1) glycoproteins gB through gE and gG through gM have
HSV-1 gB is essential for virus growth and involvedbeen identified (Allen and Coogle, 1988; Colle et al., 1992;
both in virus penetration and in fusion of neighboringFlowers and O’Callaghan, 1992; Flowers et al., 1995; Pill-
cells (Cai et al., 1988a; Highlander et al., 1988; Navarro eting et al., 1994; Robertson et al., 1991; Telford et al., 1992;
al., 1992; Sarmiento et al., 1979; Spear, 1993). In addition,Whalley et al., 1989; Zhao et al., 1992). Previously, six
studies applying anti-gB monoclonal antibodies and vari-major EHV-1 envelope glycoproteins had been mapped
ous HSV-1 gB mutants have defined domains which areusing monoclonal antibodies and a lgt11-expression li-
involved in correct protein processing, penetration, cell-brary (Allen and Yeargan, 1987). Nucleotide sequence
to-cell spread, and syncytium formation (Baghian et al.,and transcriptional analyses revealed that one of these
1993; Bzik et al., 1984; Cai et al., 1988a,b; DeLuca et al.,major glycoproteins, gp14, represents the HSV-1 gB-ho-
1982; Gage et al., 1993). Homologs of HSV-1 gB have
been identified in all herpesviral subfamilies and the gB
1 To whom correspondence and reprint requests should be ad- homologs of pseudorabies virus (PrV) and bovine herpes-dressed at Institut fu¨r Medizinische Mikrobiologie, Infektions- und Seu-
virus 1 (BHV-1) display similar functions compared tochenmedizin, Veterina¨rstr. 13, 80539 Mu¨nchen, Germany. Fax: /49-89-
2180-2597; E-mail: klaus.osterrieder@lrz.uni-muenchen.de. those of HSV-1 gB and are also essential for virus growth
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(Kopp et al., 1994; Miethke et al., 1995; Peeters et al., an electron microscope and the number of virus particles
was determined by the equation n  2.55 1 106 1 V/L1992; Rauh and Mettenleiter, 1991). Analyses of the gB-
homologous proteins in HSV-1, PrV, and BHV-1 have where n is the number of virus particles per milliliter, V
is the number of counted intact virions, and L is theshown that the cleavage of the gB precursor molecule
is not essential for BHV-1 propagation but influences number of counted latex particles.
plaque size (Kopp et al., 1994). The function of PrV gB
Plasmidscan be complemented by BHV-1 gB, but not by HSV-1
gB, and the HSV-1 gB functions can be substituted by For nucleotide sequence analyses, a 5.1-kb PstI frag-
the PrV homolog. In contrast, BHV-1 gB functions cannot ment of EHV-1 strains RacL11 and RacH was cloned into
be replaced by PrV gB (Miethke et al., 1995; Mettenleiter pTZ18R (Pharmacia) resulting in plasmids pLP5 and p06,
and Spear, 1994). respectively. Further, the entire gB open reading frame
The EHV-1 strain Rac and the plaque isolates derived of RacL11 was amplified by a standard PCR (Saiki et al.,
from different cell culture passages have been described 1988) using the thermostable Pfu polymerase (Stra-
previously. It has been demonstrated that the modified tagene) and conventional primers (5*-primer, 5*-ACG-
live vaccine strain RacH displays a deletion affecting TGAATTCATGTCCTCTGGTTGCCG-3*; 3*-primer, 5*-TAA-
the IR6 gene, and that RacH lacks a SalI restriction site ATATCCTTGGGGCCG-3*). The resulting 3.0-kb amplicon
mapping to the gB gene. RacH is apathogenic for both was cloned into pcDNAI/Amp (Invitrogen) and the recom-
the natural host and laboratory animals, whereas the low binant plasmid was termed pCB3.0. Plasmid pDES1 con-
passage derivative RacL11 causes disease in horses, taining the truncated RacH gB-gene (aa 1 to 844) under
Syrian hamsters, and mice (Hu¨bert et al., 1996; Mayr et the control of the CMV promoter has been described
al., 1968; Osterrieder et al., 1995). previously (Osterrieder et al., 1995) For the construction
The aim of this study was to analyze the functions of of pgBb/N, a 2.1-kb BglII– NruI fragment located within
the EHV-1 gB homolog. By using different EHV-1 gB- the gB gene was removed from plasmid p06 (removing
expressing cell lines, a gB-negative EHV-1 mutant, and aa 220 to 921 of EHV-1 gB) to introduce the 4-kb LacZ
the EHV-1 strains RacL11 and RacH it could be demon- expression cassette contained in pTT264A/ (Mettenleiter
strated that (i) EHV-1 gB is essential for direct cell-to-cell and Rauh, 1990; kindly provided by W. Fuchs and T. C.
spread of virions, (ii) EHV-1 gB is not significantly im- Mettenleiter). The cassette was released with BamHI and
paired in attachment to target cells, (iii) it appears not SalI, and blunt-end ligated after fill-in of 5*-overhangs
as stringently required for virus penetration as the gB with the Klenow polymerase (Sambrook et al., 1989). The
homologs are in other Alphaherpesvirinae, and (iv) the location and construction of the plasmids are depicted
carboxyterminal 37 amino acids of EHV-1 gB are dispens- in Fig. 1.
able for virus growth in cell culture.
Construction of gB-expressing cell lines and a gB-
MATERIALS AND METHODS negative EHV-1
Viruses and cells Rk13 cells (105 cells) were cotransfected by the calcium
phosphate precipitation method with 1 to 10 mg of pCB3.0EHV-1 strains RacL11 and RacH (Hu¨bert et al., 1996;
or pDES1 and 1 mg of pSV2-neo exactly as previouslyOsterrieder et al., 1996a) were propagated and titrated
described (Osterrieder et al., 1996b). Transfected cellson Rk13 cells or the equine dermal cell line Edmin337,
were grown in TC199 medium containing 10% FCS andall maintained in MEM containing 5– 10% fetal calf serum
800 mg/ml G418 (Gibco BRL) and cloned by limiting dilu-(FCS). EHV-1 virions were purified by centrifugation for
tion. The cell line expressing full-length EHV-1 gB was3 hr at 207 on 20 – 70% sucrose gradients in an SW40
termed TCgBf and the cell line expressing amino acidsrotor (30,000 rpm; Beckman) (Osterrieder et al., 1996a).
1 to 844 of gB was termed TCgBD. The cell line TCgBfFor counting physical virus particles, cells were infected
was used for the construction of gB-negative EHV-1and virions were harvested at 36 hr p.i. Cellular debris
which were obtained by cotransfection of RacL11 DNAwas removed by low-speed centrifugation (3000 g, 5 min)
(0.5– 2 mg) with varying amounts (1– 10 mg) of pgBb/N byand supernatants (1 ml) were layered onto a 30% sucrose
lipotransfection using the DOTAP reagent (Boehringer).cushion. Virions were partially purified by ultracentrifuga-
tion (SW60 rotor, 40,000 rpm, 1 hr, 47) and resuspended
DNA analyses
in 100 ml phosphate-buffered saline (PBS). These prepa-
rations were mixed with an equal volume of latex parti- Viral DNA was prepared from purified virions. Restric-
tion enzyme digests of viral DNA were separated on 0.8%cles (330 nm; Plano, Wetzlar, Germany) at a concentra-
tion of 5.1 1 107/ml and centrifuged on copper grids agarose gels and transferred to positively charged nylon
membranes (HybondN/; Amersham) by vacuum blottingusing a Beckman airfuge (80,000 g, 20 min, 207). Virions
and latex particles on 10 grid sections were counted in using 0.4 M NaOH (Reed and Mann, 1985). The 3.0-kb
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FIG. 1. Schematic illustration of the generated plasmids. Shown is the BamHI map of EHV-1 strain RacL11 and the location of the EHV-1 gB
open reading frame. The open reading frame is shaded and the transmembrane domain is indicated by a black vertical bar. Plasmids pLP5 (RacL11)
and p06 (RacH) as well as the expression plasmids pCB3.0 containing the full-length EHV-1 gB and pDES1 containing aa 1 –844 of gB are depicted.
The plasmid pgBb/N containing the Escherichia coli LacZ gene was constructed as described under Material and Methods. Restriction sites are
given: B, BamHI; Bg, BglII; P, PstI; S, SalI; E, EcoRI; N, NruI. The SalI site in the RacL11 gB open reading frame that is absent in RacH gB is indicated
by an asterisk (S*).
fragment contained in pCB3.0 and the 4.0-kb fragment 1987; kindly provided by G. P. Allen) were used as control
antibodies.contained in pTT264A/ (Fig. 1) were labeled with digoxi-
genin-11-dUTP (Boehringer) after random priming and
used as gB- and LacZ-specific probes, respectively.
Indirect immunofluorescence and Western blot
Sheets were incubated with labeled and heat-denatured
analyses
probes suspended in hybridization solution (Sambrook
et al., 1989). Detection of DNA– DNA hybrids with an anti- Detection of viral proteins in infected cells or the cell
digoxigenin AP conjugate and subsequent chemilumi- lines TCgBf and TCgBD by indirect immunofluorescence
nescence with CDP-Star were performed according to staining and subsequent flow cytometry (FACscan; Bec-
the manufacturer’s instructions (Boehringer). DNA se- ton– Dickinson) was done exactly as described pre-
quences of RacL11 and RacH gB were determined by viously (Osterrieder et al., 1995, 1996b). For SDS – 10%
cycle sequencing of plasmids pLP5 and p06 using gener- polyacrylamide gel electrophoresis (SDS– PAGE) (Laem-
ated primers which were specific for EHV-1 gB (Table 1) mli, 1970), lysates of purified virions, infected and mock-
and by an automatic DNA sequencer (Applied Biosys- infected cells, or TCgBf and TCgBD cell lines were ad-
tems). The sequences reported here were submitted to justed to a protein concentration of 5 mg/ml using a
the EMBL Databank and have been assigned the Acces- colorimetric test (BCA protein assay; Pierce) and sus-
sion Nos. X95374 and X95377. pended in sample buffer (Sambrook et al., 1989) with or
without addition of 5% 2-mercaptoethanol (2-ME). Cell
Antibodies culture supernatants of TCgBf and TCgBD cells were
harvested and concentrated (50-fold) after addition of anThe anti-gB monoclonal antibodies used were 3F6
equal volume of 4 M (NH4)2SO4 by centrifugation, and(kindly provided by G. P. Allen, Lexington, KY), 4B6, and
sample buffer was added. Separated proteins wereBe/3F8. Mab 3F6 recognizes a linear epitope located
transferred to nitrocellulose by the semidry methodbetween aa 107 and 171 of EHV-1 gB (Guo et al., 1990),
(Kyhse-Andersen, 1984) and free binding sites wereand mab 4B6 also binds to the aminoterminal subunit of
blocked with 10% nonfat dry milk in PBS containing 0.05%gB (Osterrieder et al., 1995). Mab Be/3F8 recognizes the
Tween 20 (Sigma). Detection with the respective antibod-carboxyterminal subunit of gB (Huemer et al., 1995). Rab-
ies followed, and bound antibodies were visualized withbit polyclonal antisera against gD (Flowers et al., 1995)
anti-mouse or anti-rabbit IgG alkaline phospatase conju-or IR6 (O’Callaghan et al., 1994) (both rabbit antisera
gate (Sigma) and color reaction with nitroblue tetrazoliumwere kindly provided by D. J. O’Callaghan, Shreveport,
LA), as well as anti-gM mab 13B2 (Allen and Yeargan, and 5-bromo-4-chloro-3-indolyl phosphate.
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TABLE 1
Primers Used for Cycle Sequencing of gB Genes of RacL11 and RacH
Positive-strand primers Negative-strand primers
Positiona Sequence Position Sequence
886 5*-ACCTACCCGGACTCCAGC-3* 1147 5*-TAGAACTATTGTGCCCACCC-3*
1137 5*-GCATCATCGAGGGTGGGC-3* 1475 5*-TAGGGAGCGATGTTTTCC-3*
1394 5*-CGTACGCATCGAACCACC-3* 1802 5*-GTGTAGTGCCTCCATGGC-3*
1675 5*-TCATGCACCACGCGTACC-3* 2165 5*-TAAATCTGTAGGACCCGCGG-3*
1834 5*-ACTGCATCGTCGAGGAGG-3* 2441 5*-TTTTTAGGTCGTAGGTGCGG-3*
2080 5*-TCAGCTGGAACTGGACCG-3* 2711 5*-TCATTGACGTGGGATTGG-3*
2360 5*-CGGGGGGTTCTTAATTGC-3* 2947 5*-GGCGGGAGTAGCACGTGT-3*
2622 5*-TCTTCCAACGTCACCGCC-3* 3218 5*-TCCAGGGGCAGAAACTCG-3*
3010 5*-CGATAGAAGGCCAGCTGG-3* 3445 5*-TTGAAACAACAGCGCCGG-3*
3380 5*-CGCCAGCTTTTTCAAGAG-3* 3704 5*-TTGATCATTTCGCGAGCC-3*
3649 5*-ACGGCCAGAACGAGGAGG-3* 3964 5*-TAAATATCCTTGGGGCCG-3*
a The nucleotide position of the primers is indicated according to the sequence reported by Whalley et al., 1989.
Radiolabeling of viral proteins and Chemical induction of penetration by treatment with
polyethylene glycol (PEG)immunoprecipitation
Chemically induced fusion of viral envelopes with cel-Viral proteins were labeled using [35S]methionine and
lular membranes was achieved by following the protocol[35S]cysteine (Tran35S-Label; ICN). For production of ra-
using the fusogen PEG as described by Sarmiento et al.diolabeled virions, cells were infected with 5 PFU per
(1979). Edmin337, Rk13 cells, or the cell lines TCgBf orcell and continuously labeled for 36 hr using methionine-
TCgBD were incubated with 10-fold dilutions of RacL11and cysteine-free medium which was supplemented with
or L11DgB virus preparations for 1 hr at 377. The medium10% of the normal amount of methionine and 50 mCi/
was then removed, the cells were washed once withml 35S-labeled amino acids. For immunoprecipitations,
PBS, and a 1:1 PEG:MEM solution (made by mixing 40infected cells were continuously labeled from 2 to 18 hr
g of melted PEG 6000 in 36.4 ml MEM) was added. Thepostinfection. Cells were lysed as described above and
PEG solution was removed immediately and two washesused for immunoprecipitations with mabs 3F6, Be/3F8,
followed (once with an 1:3 PEG:MEM solution and once4B6, and 13B2. Immunoprecipitations were performed
with an 1:7 PEG:MEM solution). Monolayers were thenwith 2 ml of antibodies (containing approximately 5 mg/
washed three times with MEM containing 10% FCS. Con-ml IgG) exactly as described by Flowers et al. (1995).
trol cells were treated accordingly but no PEG was pres-Labeled proteins were separated by SDS – PAGE and an-
ent in the respective medium solutions. After the finalalyzed by autoradiography.
washing step, MEM with 10% FCS was added and cells
were incubated for 3 hr at 377 to allow fusion. Cells were
Adsorption assays then overlaid with methylcellulose, and plaques or single
infected cells were counted 3 days after infection.Adsorption assays were performed by liquid scintilla-
tion counting using purified 35S-labeled virions following
RESULTSthe protocol described by Herold et al. (1991). Briefly,
Rk13 and Edmin337 cells were seeded into 96-well plates Sequence of RacL11 and RacH gB
(5000 cells per well). Cells were preincubated with PBS
supplemented with 5% FCS for 1 hr. Radiolabeled virus The nucleotide sequences of RacL11 and RacH gB
were determined by cycle sequencing of the recombinant(2.5 1 107 particles in 20 ml PBS / 5% FCS) was added
to the cells and adsorption was allowed for 0.5 to 24 hr plasmids pLP5 containing the entire RacL11 gB ORF and
p06 (containing the RacH gB ORF). The use of the primersat 47. Unbound virus was removed by five consecutive
washes with PBS and the wash solutions were collected listed in Table 1 allowed the sequence determination
of both DNA strands. The nucleotide sequences werein scintillation vials. Cells were lysed with 1% sodium
dodecyl sulfate to determine cell-associated radioactiv- subsequently analyzed using the GCG software package
(Devereux et al., 1984). The deduced RacL11 gB aminoity. Adsorption was calculated in percentages (cell-asso-
ciated cpm/input cpm1 100%). At least four independent acid (aa) sequence exhibited a 99.6% homology to those
of EHV-1 strains Ab4 and HVS25 (Telford et al., 1992;experiments were evaluated.
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FIG. 2. Amino acid sequence of RacL11 and RacH gB compared to the gB sequences determined for strains Ab4p (Telford et al., 1992) and
HVS25 (Whalley et al., 1989). Indicated are amino acid substitutions. The amino acids printed in bold and underlined are different between wild-
type RacL11 and RacH. Also shown is the replacement of amino acids 944 to 980 by 7 missense amino acids in RacH gB. Stop codons are indicated
by asterisks.
Whalley et al., 1989) (Fig. 2). RacH gB displayed four aa G) after nucleotide 2829 of the RacL11 gB nucleotide
sequence. Western blot analyses using mabs 3F6, 4B6,exchanges compared to that of the pathogenic parental
virus RacL11, i.e., replacement of Asp-14 by His, Val-397 and Be/3F8 demonstrated that both RacL11 and RacH
were able to express gB in comparable amounts in in-and Val-734 by Ala, and Gly-773 by Ala. All substitutions
are caused by nucleotide point mutations in the RacH fected cells, and that gB was incorporated in comparable
amounts in purified virions of both viruses (OsterriedergB nucleotide sequence. Of these point mutations, the
Val-397 by Ala substitution concomitantly results in the et al., 1996a) (data not shown).
loss of a SalI site in the RacH genome as has been
Construction and characterization of cell linesreported earlier (Hu¨bert et al., 1996). In addition, the car-
expressing EHV-1 gBboxyterminal 37 aa of RacH gB are replaced by 7 mis-
sense amino acids (Fig. 2), which is due to a frameshift The cell line TCgBf which constitutively expresses full-
length RacL11 gB (aa 1 to 980) was constructed by co-mutation following the deletion of 2 nucleotides (A and
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78,000 protein strongly reacted with mab 3F6 (Fig. 3),
indicating the secretion of gB into the cell culture super-
natant. When the same samples were prepared in the
absence of 2-ME and heated to 567, proteins with an Mr of
approximately 250,000 were observed in all preparations,
indicating an oligomerization of EHV-1 gB in both TCgBf
and TCgBD cells; these oligomers were also observed
in RacL11-infected cells under these conditions (Fig. 3).
Some EHV-1 gB-specific reactivity was observed in su-
pernatants of TCgBf cells, whereas a strong reaction of
the 3F6 antibody with the Mr 75,000– 78,000 gB band
was detected in TCgBD cell supernatants. Only a faint
reaction with the apparent Mr 250,000 band was ob-
served in TCgBD supernatants under these conditions
(Fig. 3). These data indicated that both subunits of
EHV-1 gB were secreted into the supernatant of TCgBD
cells, but that the oligomeric complex appears to be lessFIG. 3. Immunoblots of lysates from gB-expressing cell lines TCgBf
stable in cell culture supernatants than within cells.and TCgBD as well as Rk13 cells and RacL11-infected cells which were
Taken together, TCgBf and TCgBD cells were shown toused as controls. Cell lysates were prepared, suspended in sample
buffer with (/2-ME) or without (02-ME) 2-mercaptoethanol, incubated express EHV-1 gB and the respective gB proteins ap-
at the indicated temperatures for 3 min, and separated by SDS – 10% peared to be properly processed in that both the cleav-
PAGE. Supernatants of the cell lines were prepared as described under age and the oligomeric structure of the molecule were
Materials and Methods and treated accordingly. After gel electrophore-
retained. The fact that the gB precursor molecule insis, the proteins were transferred to nitrocellulose and probed with
TCgBD cells was reduced in size and that the gB sub-anti-gB mab 3F6. Molecular weights are indicated in thousands and
gB-precursor molecules in lysates of the TCgBf and TCgBD cell lines units are secreted into the cell culture supernatant was
are marked by arrowheads. probably due to the absence of the transmembrane por-
tion of EHV-1 gB produced by this cell line.
transfection of plasmids pCB3.0 and pSV2-neo into Rk13
cells. Isolated G418-resistant cell clones were selected Construction and analysis of a gB-negative EHV-1
for expression of EHV-1 gB by indirect immunofluores-
cence analysis in a FACScan flow cytometer using the The cell line TCgBf was used to engineer RacL11
viruses which are devoid of an intact gB ORF. To thisanti-EHV-1 gB mab 4B6. Accordingly, the cell line TCgBD
expressing aa 1 to 844 of EHV-1 gB was isolated after end, the Escherichia coli LacZ gene under the control
of the PrV gG promoter (Mettenleiter and Rauh, 1990)cotransfection of pDES1 and pSV2-neo into Rk13 cells. In
both cell lines, 95% of the cells were producing was inserted into the gB gene by cotransfection of
TCgBf cells with pgBb/N plasmid DNA and RacL11 ge-EHV-1 gB as analyzed by flow cytometry (data not
shown). The cell lines were further analyzed by immu- nomic DNA (see Fig. 1 and Material and Methods). Virus
progeny was plated under an agarose overlay whichnoblotting under different conditions using anti-EHV-1 gB
mab 3F6. Cell lysates and cell culture supernatants of contained Bluo-Gal. Blue-staining virus plaques were
picked, purified by six consecutive rounds of plaqueTCgBf and TCgBD were prepared, suspended in sample
buffer with or without the addition of 2-ME, and separated purification, and the progeny virus was termed L11DgB.
To confirm the correct insertion of LacZ sequences intoby SDS– 10% PAGE. In the presence of 2-ME and after
heating of the samples to 957, bands with apparent Mrs the gB gene, viral DNA of RacL11 or L11DgB was pre-
pared and cleaved with the restriction enzymes BamHIof 75,000– 78,000 and 138,000 reacted with mab 3F6 in
lysates of TCgBf. Thus, the reaction pattern of TCgBf cell or PstI. DNA fragments were separated on 0.8% agarose
gels, transferred to nylon membranes, and probed withlysates with mab 3F6 was very similar to that of RacL11-
infected cell lysates prepared at 16 hr after infection (Fig. digoxigenin-labeled EHV-1 gB or LacZ sequences pre-
pared from plasmids pCB3.0 or pTT264A/, respectively.3). No detectable reactivity with the 3F6 antibody was
obtained when TCgBf cell culture supernatants were an- As expected, fragments of 20.1-kb (BamHI-A fragment)
and 6.9-kb (BamHI-I fragment) hybridized with pCB3.0alyzed (Fig. 3). In TCgBD cell lysates, the same Mr
75,000– 78,000 band as was in lysates of TCgBf cells or in RacL11 DNA after cleavage with BamHI. In PstI-di-
gested RacL11 DNA, a 5.1-kb fragment hybridized withRacL11-infected cell lysates was detected. However, the
uncleaved gB-precursor molecule was reduced in size that probe (Fig. 4). No reactivity was obtained with
RacL11 DNA after hybridization with the LacZ-specificand exhibited an apparent Mr of 120,000 (Fig. 3). In cell
culture supernatants of TCgBD cells, an Mr 75,000– probe (Fig. 4). In DNA of L11DgB cleaved with BamHI,
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in L11DgB-infected cells, anti-gM mab 13B2 specifically
immunoprecipitated gM (Fig. 5A).
The absence of gB expression in L11DgB-infected
Rk13 cells in the presence of other gene products was
confirmed by Western blot analysis using anti-gB mab
3F6, anti-gM mab 13B2, a monospecific anti-gD antise-
rum, and a monospecific antiserum directed against the
early IR6 protein. Whereas in both RacL11- and L11DgB-
infected cell lysates EHV-1 gD, EHV-1 gM, and the early
IR6 protein were readily detectable at 24 hr p.i., the spe-
cific staining pattern with anti-gB mab 3F6 was only ob-
served in RacL11-infected cell lysates and not in those
of L11DgB (Fig. 5B).
To further ensure the absence of EHV-1 gB expression
in L11DgB-infected cells, Rk13 cells infected with RacL11
or L11DgB were analyzed by indirect immunofluorescence
using anti-gB mabs 4B6 and Be/3F8 as well as anti-gM mab
13B2. Cells were infected with 5 PFU per cell of RacL11 or
L11DgB and harvested at 36 hr after infection. A specific
staining of approximately 80% of the cells was observed
with all antibodies in RacL11-infected cells (Fig. 6). In con-
trast, anti-gB mabs 4B6 and Be/3F8 did not react with
L11DgB-infected Rk13 cells, whereas more than 70% of the
cells strongly reacted with anti-gM mab 13B2 (Fig. 6).
These data confirmed that no detectable gB reactivity
FIG. 4. Southern blot analysis of RacL11 and L11DgB DNA cleaved was obtained after infection of cells with L11DgB, but
with the restriction enzymes BamHI or PstI and probed with a gB- that infection occurred as reflected by the presence of
specific probe prepared from plasmid pCB3.0 (gB) or a LacZ-specific the early IR6 as well as the late gM and gD gene prod-
probe derived from pTT264A/ (LacZ). The sizes of the reactive frag-
ucts. Since neither the amino- nor the carboxyterminalments are indicated in kb.
subunit of EHV-1 gB was detected in L11DgB-infected
Rk13 cells by anti-gB antibodies in three different tests,
it was concluded that L11DgB is not capable of encodingfragments of 20.1 kb (BamHI-A) and 8.8 kb in size re-
acted with the pCB3.0 probe (Fig. 4). Only the 8.8-kb for an intact or aberrant form of EHV-1 gB.
BamHI fragment in L11DgB DNA hybridized to the la-
beled LacZ probe (Fig. 4). In L11DgB DNA cleaved with Growth of the L11DgB mutant on different host cells
PstI, a 7.0-kb fragment was detected by both gB and
LacZ sequences as probes (Fig. 4). From these data we To analyze the growth properties of the gB-negative
L11DgB mutant, of the parental RacL11 virus, and of theconcluded that the LacZ gene was correctly inserted
into gB-encoding sequences. RacH virus, gB-complementing cells (TCgBf), the cell line
expressing truncated gB (TCgBD), and the cell lines Rk13As deduced from the nucleotide sequence of the
EHV-1 gB – LacZ deletion construct, the expression of an and Edmin337 were infected with the respective viruses.
Results of subsequent titration experiments are summa-aminoterminal 223-aa truncated gB polypeptide by
L11DgB is theoretically possible. Anti-gB mab 3F6, which rized in Table 2. L11DgB virus, which was produced on
complementing TCgBf cells and had gB incorporated inrecognizes a linear epitope in this region (between aa
107 and 171; Guo et al., 1990), mab 4B6, and mab Be/ viral envelopes as shown by Western blot analysis (data
not shown), produced plaques on complementing cells3F8 were used for immunoprecipitations to analyze 35S-
labeled virion polypeptides produced after infection which stained blue in the presence of Bluo-Gal (Fig. 7)
and exhibited titers which were comparable to that of(m.o.i.  5) with RacL11 or L11DgB. After SDS– 10%
PAGE of the immunocomplexes, bands of Mr 138,000, wild-type RacL11 and those of RacH (Table 2). In con-
trast, viral titers of L11DgB were reduced by approxi-75,000 to 78,000, and 55,000, and also the high Mr form
of EHV-1 gB (Mr 250,000) were detected after immunopre- mately 10
5-fold when virus was produced and titrated on
TCgBD, Rk13 , or Edmin337 cells, but single blue-stainingcipitations with all anti-gB antibodies in RacL11-infected
cells. In contrast, no reactivity with either of the mabs cells were observed in the presence of Bluo-Gal (Fig. 7).
However, when L11DgB was produced on noncomple-was obtained with radiolabeled lysates of L11DgB-in-
fected Rk13 cells (Fig. 5A). However, both in RacL11- and menting cells and titrated on TCgBf cells, titers of approx-
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FIG. 5. (A) Immunoprecipitations of 35S-labeled Rk13 cell lysates infected with L11DgB (lanes 1, 2, 3, and 7) or RacL11 (lanes 4, 5, 6, and 8) using
anti-gB mabs 3F6 (lanes 1 and 4), 4B6 (lanes 2 and 5), and Be/3F8 (lanes 3 and 6) or mab 13B2 (lanes 7 and 8), which is directed against gM.
Immunocomplexes were separated by SDS –10% PAGE and detected by autoradiography. Molecular weights are indicated in thousands. (B) Western
blot analysis of RacL11- and L11DgB-infected cell lysates. Lysates of infected Rk13 cells (m.o.i.  5) were harvested at 24 hr after infection, separated
by SDS – 10% PAGE, and transferred to nitrocellulose. Different sheets were incubated with anti-gB mab 3F6 (gB), anti-gM mab 13B2 (gM), or
monospecific rabbit sera against gD (gD) and the early IR6 protein (IR6). Molecular weights are indicated in thousands.
imately 103/ml were observed indicating that virions phe- to infect target cells, although at a largely reduced effi-
ciency, as demonstrated by the production of viralnotypically lacking gB —although with reduced effi-
ciency— were also able to enter cells. The viral titers plaques on complementing TCgBf cells and single in-
fected cells on noncomplementing cells. To further char-obtained with both RacL11 and RacH virus grown on
TCgBf cells were virtually indistinguishable from each acterize the efficiency of infection by the gB-negative
EHV-1 mutant, the particle per PFU ratios of RacL11 andother on all cell lines (Table 2). These data indicated
that: (i) gB is essential for EHV-1 growth, since gB-nega- L11DgB produced on both complementing TCgBf and
noncomplementing Rk13 cells were determined (Table 3).tive EHV-1 are able to produce virus plaques only on
cells complementing for gB in trans. (ii) Phenotypically The mean particle per PFU ratio of L11DgB produced
on Rk13 cells (6308) exceeded those of L11DgB producedgB-complemented L11DgB is able to enter noncomple-
menting target cells but does not form plaques, demon- on complementing cells (64) by 99-fold. Similarly, the
RacL11 particle per PFU ratio (78) was exceeded by 81-strating the essentiality of EHV-1 gB in direct cell-to-
cell spread of virions. (iii) L11DgB virions phenotypically fold by that of L11DgB produced on noncomplementing
cells. The increased particle per PFU ratio of L11DgBlacking gB are able to infect both complementing and
noncomplementing cells although at an approximately produced on Rk13 cells compared to phenotypically com-
plemented L11DgB or parent RacL11 indicated that gB-1000-fold reduced efficiency compared to wild-type
RacL11. (iv) Since RacH, which had aa 944 to 980 re- negative EHV-1 particles are impaired at a step early in
infection.placed with 7 missense amino acids, grows on noncom-
plementing cells, this portion of gB is apparently not es-
sential for virus growth in cultured cells. (v) The cell line Binding of L11DgB to target cells
TCgBD lacking the transmembrane domain of EHV-1 gB
To determine the binding of virions to target cells, Rk13(aa 853 to 868; Whalley et al., 1989) did not complement
or Edmin337 cells were reacted with purified, radiola-for the production of infectious virus progeny and plaque
beled RacL11 or L11DgB virions. L11DgB virions wereformation of L11DgB, suggesting that membrane anchor-
produced on either complementing TCgBf cells or Rk13ing of EHV-1 gB is essential for virus growth.
cells. In pilot experiments, the binding kinetics of RacL11
Specific infectivities of RacL11 and L11DgB and L11DgB virions produced on complementing and
noncomplementing cells were determined. The experi-The titration experiments had demonstrated that
L11DgB produced on noncomplementing cells was able ments demonstrated that the equilibrium of virus binding
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ences in either the kinetics or the total binding of RacL11
or L11DgB to the target cells could be demonstrated.
After a 2-hr adsorption period at 47, 9.2 { 0.7% of RacL11
virions, 8.9 { 0.4% of L11DgB virions produced on com-
plementing cells, and 8.0 { 0.6% of L11DgB virions pro-
duced on noncomplementing cells had bound to Rk13
cells. Similar values were determined for the binding of
purified virions to Edmin337 cells, in that 9.8 { 1.1%
(RacL11), 9.5 { 0.9% (L11DgB produced on TCgBf cells),
and 8.9 { 0.5% (L11DgB produced on Rk13 cells) had
bound to cells at this time point. From these results it was
apparent that virions lacking gB were slightly impaired in
binding to target cells, and that the reduced attachment
of L11DgB that was not statistically significant was not
responsible for the greatly increased particle per PFU
ratio of gB-negative EHV-1.
PEG-induced infectivity of gB-negative L11DgB
The above-described experiments had shown that
EHV-1 gB is absolutely essential for direct cell-to-cell
spread of virions and that the specific infectivity of
EHV-1 is greatly reduced in the absence of gB. However,
the reduced specific infectivity of L11DgB was obviously
not caused by a significantly impaired binding of gB-
FIG. 6. Flow cytometric analyses of Rk13 cells. Cells were infected negative virions to target cells. The gB homologs of
either with RacL11 or with L11DgB at an m.o.i.  5, harvested at 36 HSV-1, PrV, and BHV-1 are essential for penetration of
hr p.i., fixed, permeabilized, and probed with anti-gB mabs 4B6 and
virions into target cells (Rauh and Mettenleiter, 1991;Be/3F8 or anti-gM mab 13B2. The x axis shows the log10 fluorescence
Miethke et al., 1995; Sarmiento et al., 1979). To addressintensity 1 (FL1), and the y axis shows the number of cells. Gray-shaded
curves represent L11DgB-infected cells, black solid lines represent the question whether L11DgB viral titers or the number
RacL11-infected cells, and gray solid lines represent uninfected control of infected cells of L11DgB produced on noncomple-
cells. menting cells could be increased by chemically inducing
virus penetration, experiments were performed in which
the fusogenic agent PEG was used for the fusion of viralwas approached at 6 to 7 hr after infection where 18 to
23% of the input radioactivity remained associated with and cellular membranes (Sarmiento et al., 1979). To this
end, both RacL11 and L11DgB virus were generated onthe cells. No major differences were observed in the
kinetics or the total amount of binding of virions to either TCgBf or Rk13 cells and titrated on these cell lines in
the presence or absence of PEG. gB0 PrV (Rauh andRk13 or Edmin337 cells. Likewise, no significant differ-
TABLE 2
Titersa of Wild-Type RacL11, RacH, and L11DgB on Different Host Cells
TCgBfb TCgBDb Rk13
b Edmin337b
Cell linec RacL11 RacH L11DgB RacL11 RacH L11DgB RacL11 RacH L11DgB RacL11 RacH L11DgB
TCgBF 9.3 1 105 1.1 1 106 1.2 1 106 1.4 1 106 6.9 1 105 3.1 1 103 2.9 1 106 1.1 1 106 1.1 1 103 8.2 1 105 9.1 1 105 9.2 1 102
2.5 1 106 9.7 1 105 8.5 1 105 9.8 1 105 1.3 1 106 9.7 1 102 7.7 1 105 9.2 1 105 2.3 1 103 1.3 1 106 1.3 1 106 2.2 1 103
TCgBD 9.7 1 105 8.1 1 105 10d 1.4 1 106 7.7 1 105 10 2.2 1 106 1.0 1 106 10 1.2 1 106 8.6 1 105 10
8.4 1 105 1.5 1 106 10 2.1 1 106 1.9 1 106 10 9.1 1 105 2.2 1 106 10 2.9 1 106 9.6 1 105 10
Rk13 3.3 1 106 2.1 1 106 10 9.3 1 105 8.4 1 105 10 9.0 1 105 8.9 1 105 10 9.0 1 105 9.7 1 105 10
1.4 1 106 9.4 1 105 10 1.2 1 106 2.4 1 106 10 1.1 1 106 1.3 1 106 10 2.4 1 106 1.7 1 106 10
Edmin337 2.8 ts 106 8.9 1 105 10 1.7 1 106 8.5 1 105 10 9.8 1 105 8.3 1 105 10 2.1 1 106 7.9 1 105 10
2.4 1 106 2.7 1 106 10 9.5 1 105 1.1 1 106 10 8.4 1 105 1.9 1 106 10 1.7 1 106 9.8 1 105 10
a Titers were determined as the number of plaques counted after 5 days under a methylcellulose overlay.
b Cell lines on which progeny virus was produced.
c Cell lines on which virus progeny was titrated. The results of two independent experiments are given.
d No plaques were counted at the lowest dilution tested (1001).
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FIG. 7. Photographs of TCgBf and Rk13 cells infected with L11DgB. Cells were infected with the viruses and overlaid with methylcellulose
containing 300 mg/ml Bluo-Gal. Three days after infection, cells were fixed with formalin and pictures were taken with a Leica camera on an inverted
microscope. Whereas viral plaques were readily detected on TCgBf cells infected with L11DgB, only single blue-staining cells were observed after
infection of Rk13 cells with L11DgB.
Mettenleiter, 1991; kindly provided by T. C. Mettenleiter, treated for 1 min with a citrate buffer (pH 3.0) to inactivate
virus that had not entered cells and to avoid plaque for-Insel Riems, Germany) was used as a control in these
experiments. RacL11, gB-negative L11DgB, and gB0 PrV mation by gB-complemented input virus in subsequent
titration experiments (Highlander et al., 1988). The pro-were produced by infecting the respective cells at an
m.o.i.  5. At 90 min after infection, infected cells were duced virus preparations were titrated, cells were treated
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TABLE 3
Particle/PFU Ratios of RacL11 and L11DgB Produced on Different Cell Lines
RacL11 (Rk13)a L11DgB (Rk13)a L11DgB (TCgBf)a
Exptb Particles PFUc Ratio Particles PFUc Ratio Particles PFUc Ratio
1 2.8 1 108 2.7 1 106 104 8.2 1 106 2.3 1 103 3565 4.8 1 107 1.2 1 106 40
2 9.6 1 107 1.9 1 106 51 1.1 1 107 1.3 1 103 8461 1.4 1 108 2.2 1 106 64
3 1.1 1 108 1.4 1 106 79 6.9 1 106 1.0 1 103 6900 8.7 1 107 9.8 1 105 89
Meand 78 6308 64
a The respective viruses were produced on the cell line indicated in brackets.
b Three independent experiments were performed.
c The plaque-forming units were determined by titration on Rk13 cells (RacL11) or TCgBf cells (L11DgB).
d The mean particle/PFU ratios from the three experiments are given.
with PEG, and virus-induced plaques or single infected complementing cells, virtually no difference in virus titers
with or without PEG treatment was observed, thus resem-cells obtained after treatment with the fusogen were
counted and compared to those obtained on untreated bling the results obtained with wild-type RacL11 virus
(Table 4). Similarly, the number of blue-staining cells ob-cells. PEG treatment of cells after titration of RacL11 virus
generally led to a slight reduction in virus titers both served after titration of phenotypically complemented
L11DgB virus on Rk13 cells was slightly decreased afteron gB-complementing and on noncomplementing cells
(Table 4). L11DgB virus that phenotypically lacked gB PEG treatment (ratios: 0.8 and 0.9; Table 4). In contrast,
the titers of gB0 PrV could be enhanced by PEG treatmentexhibited virus titers which were increased in three inde-
pendent experiments by 21- to 41.4-fold subsequent to by 470- to 883-fold in three independent experiments
(Table 4). Therefore, by chemically inducing membranePEG treatment of TCgBf cells (Table 4). Similarly, the
number of infected cells which were observed for gB- fusion with PEG, the titers of gB0 PrV were enhanced by
11- to 35-fold more than those of L11DgB. These resultsnegative L11DgB on noncomplementing Rk13 cells after
PEG treatment was increased to nearly the same extent, were confirmed by PEG experiments in which L11DgB
and PrV gB0 were produced on noncomplementing cellsi.e., from 15.1- to 22.2-fold (Table 4). The number of in-
fected cells was determined by counting blue-staining without low pH treatment. Whereas titers of gB-negative
L11DgB were increased by only 2.8-, 5.3-, and 7.5-foldcells after addition of the chromogen Bluo-Gal to fixed
cells. In another series of experiments, L11DgB viruses after PEG treatment, those of gB0 PrV were increased
by 69-, 94-, and 124-fold in three independent experi-were produced on the gB-complementing cell line TCgBf
and titrated in the absence or presence of PEG. When ments. The results described here for an enhancement
of gB0 PrV infectivity by PEG closely resembled thoseTCgBf-produced L11DgB virus progeny was titrated on
TABLE 4
Influence of PEG on the Number of Plaques or Infected Cells
RacL11 (Rk13)a L11DgB (Rk13)a,b L11DgB (TCgBf)a,b PRV gII0 (Rk13)
Cell linec /PEG 0PEG Ratiod /PEG 0PEG Ratio /PEG 0PEG Ratio /PEG 0PEG Ratio
TCgBf 3.2 1 106 2.7 1 106 1.2 9.1 1 104 2.2 1 103 41.4 1.3 1 106 1.2 1 106 1.1 9.4 1 103 2 1 101 470
1.1 1 106 1.9 1 106 0.6 3.3 1 104 1.3 1 103 25.3 1.9 1 106 2.2 1 106 0.9 5.3 1 104 6 1 101 883
8.8 1 105 1.4 1 106 0.6 2.1 1 104 1.0 1 103 21.0 8.3 1 105 9.8 1 105 0.8 3.7 1 104 6 1 101 617
Rk13 8.1 1 105 9.8 1 105 0.8 9.1 1 103 4.1 1 103 22.2 1.1 1 106 1.2 1 106 0.9 ND ND
9.1 1 105 2.2 1 106 0.4 1.1 1 104 7.3 1 102 15.1 7.9 1 105 1.1 1 106 0.8 ND ND
7.4 1 105 1.0 1 106 0.7 3.9 1 104 2.6 1 103 19.5 NDe ND ND ND
a RacL11 or L11DgB were produced on the cell lines indicated.
b For L11DgB, the number of plaques (on TCgBf cells) or the number of single infected cells (noncomplementing Rk13 cells) was determined at
Day 3 p.i.
c Cell lines on which virus progeny was titrated. The results of three independent experiments are given.
d Ratio of PFU or single infected cells with and without PEG treatment.
e Not determined.
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reported earlier for gB0 PrV using MDBK cells (Rauh ments revealed that EHV-1 gB —like all other gB homo-
and Mettenleiter, 1991). From the observations it was logs analyzed to date—is essential for virus growth in
concluded that EHV-1 gB does not appear to be as strin- vitro in that the L11DgB mutant virus could not be propa-
gently required for penetration into target cells compared gated on noncomplementing cells. Further analyses of
to that of other Alphaherpesvirinae, since (i) virus titers the growth of RacH on noncomplementing cells as well
of 103/ml were observed for L11DgB produced on non- as the growth of RacL11, RacH, and L11DgB on the cell
complementing cells, and since (ii) the increase in num- line expressing truncated EHV-1 gB (TCgBD) showed
bers of viral plaques or of single infected cells after artifi- that aa 944 to 980, but apparently not the transmembrane
cial membrane fusion using PEG was significantly domain located between aa 853 to 868 of the polypep-
smaller for L11DgB than that determined for gB0 PrV and tide, are dispensable for virus growth.
those reported for gB-negative HSV-1 or BHV-1 mutants The essentiality of EHV-1 gB for virus growth in cul-
(Miethke et al., 1995; Sarmiento et al., 1979). tured cells is primarily due to its absolute requirement
for direct cell-to-cell spread of virions as shown by the
absence of L11DgB virus plaques on noncomplementingDISCUSSION
cells. Virus binding assays demonstrated that EHV-1 gB,
The presented study describes experiments which like its homologs in other Alphaherpesviruses, is not sig-
were conducted to elucidate the structure and functions nificantly involved in the overall binding of EHV-1 to the
of EHV-1 glycoprotein gB. The EHV-1 strain RacL11 and target cell. However, an elevated particle per PFU ratio
its high cell culture passage derivative RacH (Hu¨bert et of L11DgB compared to wild-type RacL11 indicated that
al., 1996; Osterrieder et al., 1996a), which express differ- gB-negative EHV-1 are impaired in an early step of infec-
ent gB molecules, and a gB-negative RacL11 virus tion. The involvement of EHV-1 gB in virus penetration
(L11DgB) produced on a EHV-1 gB-complementing cell was analyzed by artificially inducing membrane fusion
line were investigated. by PEG. Using PEG, both increased numbers (up to 41.4-
The first series of experiments addressed the structure fold) of viral plaques on complementing cells and in-
of both RacL11 and RacH gB. Nucleotide sequence anal- creased numbers of infected cells on noncomplementing
yses and the deduced aa sequences revealed a total of cells were observed after plating of L11DgB produced
four aa substitutions in RacH gB compared to RacL11 in noncomplementing cells. However, the titers of gB0
gB and a replacement of the carboxyterminal 37 aa by PrV which was used as a control in these experiments
7 missense aa in RacH gB. Whereas the first aa substitu-
were enhanced by up to 883-fold. The absence of gB
tion [His (RacH) for Asn] maps to the N-terminal signal
reactivity in L11DgB-infected cells and purified virionssequence (Whalley et al., 1989), the remaining three sub-
as assayed by Western blotting, flow cytometry, and im-stitutions are located in the extracytoplasmic domain of
munoprecipitations suggests that EHV-1 gB is clearlythe molecule. All changes represent conservative aa ex-
involved in, but might not be as stringently required for,changes (Ala for Val, positions 397 and 734; Ala for Gly,
penetration, as is gB in other Alphaherpesvirinae.position 773) and do not appear to influence the ability
The fact that virus penetration and viral cell-to-cellof the glycoprotein to aggregate to oligomeric structures
spread which both depend on fusion of membranes areas demonstrated by Western blot analyses. However,
related but distinct processes has been shown pre-similar conservative aa exchanges were reported for a
viously (Davis-Poynter et al., 1994; Rauh and Mettenleiter,temperature-sensitive HSV-1 mutant (Bzik et al., 1984)
1991). Hence, the findings reported here confirm andand truncations or mutations in the HSV-1 gB cytoplasmic
extend previous results on various homologs of herpesvi-tail as observed in RacH gB were associated with syncy-
ral glycoproteins indicating that homologous glycopro-tium formation (Baghian et al., 1993; Bzik et al., 1984;
teins (gB, gD, gM) may confer related but not strictlyKousoulas et al., 1984). Since RacH is avirulent for labo-
identical functions in different herpesviral systemsratory animals and the natural host (Hu¨bert et al., 1996;
(Baines and Roizman, 1993; Ligas and Johnson, 1988;Mayr et al., 1968), studies are in progress to analyze
Miethke et al., 1995; Osterrieder et al., 1996b; Rauh andwhether the mutations in RacH gB are involved in the
Mettenleiter, 1991; Sarmiento et al., 1979). To further elu-more prominent syncytium formation of RacH on different
cidate the relationships of the gB homologs of differentcell lines (Neubauer et al., unpublished) and also in the
herpesviruses, a mutual replacement of the gB homologsavirulence of RacH in animals by introducing RacH gB
has already been reported (Mettenleiter and Spear, 1994;into L11DgB.
Miethke et al., 1995). The extension of these studies us-The second series of experiments reported in this
ing EHV-1 gB might provide the possibility of gainingstudy addressed the functions of EHV-1 gB. To this end,
more insight into the mechanisms by which various gBcell lines stably expressing different forms of gB and a
homologs confer their functions in virus entry and directgB-negative EHV-1 mutant (L11DgB) were constructed,
and functional analyses were conducted. The experi- cell-to-cell spread.
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